Canaccord Genuity analyst Aravinda Galappatthige maintained a Buy rating on TMX Group (TMXXF – Research Report) yesterday and set a price ...

In a report released today, Aravinda Galappatthige from Canaccord Genuity maintained a Hold rating on Telus (TU – Research Report), with a ...

AxoGen (NASDAQ:AXGN – Get Free Report) had its price objective increased by investment analysts at Canaccord Genuity Group from $18.00 to $22.00 in a research report issued on Monday,Benzinga reports.

Canaccord Genuity Group Inc. (TSE:CF – Get Free Report)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$9.46 and traded as ...

Power Metals Corp ("Power Metals" or the "Company") (TSXV: PWM) (FRANKFURT: OAA1) (OTCQB: PWRMF) is pleased to announce the appointment of Canaccord Genuity Corp. ("Canaccord Genuity") as financial ...

Fintel reports that on January 31, 2025, Canaccord Genuity downgraded their outlook for Intra-Cellular Therapies ...

Fintel reports that on January 31, 2025, Canaccord Genuity initiated coverage of Dave (NasdaqGM:DAVE) with a Buy ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial ...

Pan American Silver Corp (PAAS) stock saw a modest uptick, ending the day at $23.86 which represents a slight increase of $0.65 or 2.80% from the prior close of $23.21. The stock opened at $23.2 and ...

CEO Kevin Hykes highlighted strong revenue growth of $15.3 million for Q4 2024, representing a 36% increase year-over-year. U.S. Heart Failure revenues grew by 41%, supported by the expansion to 48 ...

CEO John McKenzie highlighted a robust Q4 performance, with revenue increasing 30% year-over-year, supported by notable growth across Global Solutions, Insights, and Analytics (GSIA), Derivatives ...